‹ ›
MYP_066968
← PREVIOUS NEXT → BACK
Basic Information
Envelope glycoprotein gp160, C46
Antimicrobial
Antiviral
Antiviral ▸ Antiviral mechanism ▸ Viral fusion inhibition ▸ Fusion inhibitor
Standard
46 amino acids
C263H381N67O82S
Standard
Sequence
WMEWDREINNYTSLIHSLIEESQNQQEKNEQELLELDKWASLWNWF
Physicochemical Analysis
5825.30 Da
4.22
-7.13
-7.40
-0.1550
-1.06
0.58
-0.10
55.63
78.48
0.1522
28990.00
28990.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
2476.58
-18.64
83.0
77.0
195.0
413.0
13.0
54.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0030184 VERIFIED: NO
Provenance & Taxonomy
isolate HXB2 group M subtype B,HIV-1 [Virus]
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
Bio-Activity Profile
Antimicrobial Antiviral
HIV-1
RECORD: Rec_0047310 VERIFIED: YES
Provenance & Taxonomy
not reported [other]
Structure & Mods
linear peptide; DSSP H 95.7%, E 0.0%, T 0.0%, C 4.3% [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antiviral Antimicrobial
PaperHIPdb: a database of experimentally validated HIV inhibiting peptides PMID23359817 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/23359817/
RECORD: Rec_0286094 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
Bio-Activity Profile
Antiviral Fusion inhibitor
Qualitative inhibition
PaperHighly potent synergistic combinations of human immunodeficiency virus (HIV) fusion inhibitors PatentUS7919101